Clinical validation study of a novel prognostic risk prediction model (CHIP Score) for interventional therapy in patients with NSTE-ACS—a single-center retrospective cohort study based on 348 patients
In this study, the CHIP score demonstrated moderately satisfactory predictive efficacy in forecasting the risk of MACCE among NSTE-ACS patients. Hyperlipidemia and coronary CTO were independent risk factors for MACCE in CHIP patients.
Authors
- Yuan Zhang (ORCID: https://orcid.org/0000-0002-0127-7736)
- Qichang Zhu
- Jiaxin Liu
- Xin Wang
- Jiayu Meng
- Hongwei Tian
Institutions
- Ningxia Medical University (CN)
- Ningxia Medical University General Hospital (CN)
- The Fourth People's Hospital of Ningxia Hui Autonomous Region (CN)
Publication Details
- Journal
- BMC Cardiovascular Disorders
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1186/s12872-025-05486-x
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00